Operator
Good day, and thanks for standing by. Welcome to the Rhythm Prescribed drugs Convention Name. (Operator Directions) Please be suggested that right this moment’s convention is being recorded. I might now like at hand the convention over to your speaker right this moment, Dave Connolly, Investor Relations. Please go forward.
David Connolly
Head of Investor Relations & Company Communications
Thanks, Daniel, and good afternoon, everybody, and welcome. This afternoon, we issued a press launch with the Section III high line outcomes for our EMANATE trial. You possibly can entry the press launch in addition to the slides that we’ll be reviewing right this moment by going to the Traders part of our web site. Listed on Slide 3 are the audio system for right this moment’s name. David Meeker, Chair, President and Chief Govt Officer, will stroll by way of these knowledge. And Dr. Alastair Garfield, our Chief Scientific Officer; and Hunter Smith, our CFO, can be found to reply questions on this name as nicely.
Earlier than we get began, I want to remind everybody that these statements we make on this convention name will embody forward-looking statements. Precise occasions or outcomes might differ materially from these expressed or implied by any forward-looking statements on account of numerous dangers, uncertainties and different elements, together with these set forth within the threat elements in our Threat Components